Stapokibart (CM310) targets IL-4Rα for the treatment of type 2 inflammation
Article in iScience (September 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in iScience (September 2024)
Article in Exploration of Asthma & Allergy (August 2024)
Article in Journal of Asthma and Allergy (July 2024)